Cardura XL (doxazosin mesylate extended-release tablets) have been made available by Pfizer for the treatment of benign prostatic hyperplasia (BPH). Unlike Cardura, which is indicated for both BPH and hypertension, Cardura XL has only been approved for treating BPH.